Clinical Trial Update: Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

View source ↗

Summary

A completed study validating a predictive nomogram for response or resistance to targeted therapies in metastatic clear cell renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Snippet

Sponsor: Rennes University Hospital | Conditions: Metastatic Clear Cell Renal Cell Carcinoma | Status: COMPLETED